New Therapy – Commercialization Grants Program The mission of the New Therapy - Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. Proposals for research originating from outside the United States are welcome. Funding Portfolio: Applicants are encouraged to view a list of New Therapy – Commercialization projects that have been funded in the past.
Posted on: Sat, 27 Jul 2013 09:23:28 +0000